Procter & Gamble reported $87.0B of revenue over the trailing twelve months, +3.3% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $87.0B (to Q4 2026). Net income: $16.0B, trailing twelve months to Q4 2026. Free cash flow: $15.1B, trailing twelve months to Q4 2026. Operating margin: 23%, trailing twelve months to Q4 2026.

PGProcter & Gamble

Consumer Defensive

$151.25-1.8% 1Y

$151.25

$136.0452 weeks$165.95

PG as reported

Procter & Gamble reported $87.0B of revenue over the trailing twelve months, +3.3% on the year before. 11 reported series are charted on this page, each one as filed.

$87.0B

Revenue, trailing twelve months · to Q4 2026 · +3.3% against the twelve months before

Net income: $16.0B
Net income · +0.45% year on year · trailing twelve months to Q4 2026
Free cash flow: $15.1B
Free cash flow · +7.9% year on year · trailing twelve months to Q4 2026
Operating margin: 23%
Operating margin · trailing twelve months to Q4 2026

Details›

Every series Ryufin has for PG, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$87.0B	+3.3%	Q4 2026
Net income	$16.0B	+0.45%	Q4 2026
EPS	$6.62	+1.7%	Q4 2026
Gross margin	50%	n/a	Q4 2026
Operating margin	23%	n/a	Q4 2026
Net margin	18%	n/a	Q4 2026
ROE	31%	n/a	Q4 2026
ROA	13%	n/a	Q4 2026
ROIC	20%	n/a	Q4 2026
Free cash flow	$15.1B	+7.9%	Q4 2026
P/E	22.9	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.